No.4
公告
2026/10/30 17:30
登記住所・代理人の変更/會社祕書役の異動
CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT
📄 開啟公告原文
刪除
No.3
公告
2026/10/08 19:38
事業の狀況
VOLUNTARY ANNOUNCEMENT INSULIN DEGLUDEC AND INSULIN ASPART INJECTION OBTAINED MARKETING APPROVAL FROM THE CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
📄 開啟公告原文
刪除
No.2
公告
2026/09/30 22:41
中間報告書
Interim Report 2026
📄 開啟公告原文
刪除
No.1
公告
2026/09/23 20:00
內部情報(インサイド・インフォメーション)
INSIDE INFORMATION FILING WITH THE CSRC IN RELATION TO THE PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION
📄 開啟公告原文
刪除